• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD. BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD. BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383083
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem Extravasation (1842)
Event Date 05/16/2019
Event Type  malfunction  
Manufacturer Narrative
Device evaluated by mfr: a device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It has been reported that one bd intima-ii¿ closed iv catheter system has been found containing mixed product during use.The following has been provided by the initial reporter: it was found extravasation, catheter was shorter than usual, and felt dull.(b)(6): after the puncture ended the afternoon of the stay, an external seepage occurred, and after the nurse pulled out the needle, checked the length of the catheter and found that the catheter was shorter than usual.Other nurses also reacted to this batch of retention needles obviously feel the strong feeling of the back-retracting needle core, not good to fight, affecting the success rate of puncture.
 
Manufacturer Narrative
H.6.Investigation: a device history review was conducted for lot number 8262052.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.Unfortunately because the needle was removed from the returned sample our engineers were unable to evaluate the retraction speed.Comparison to the retention samples for this lot determined that the shortened catheter was most likely the result of mixed products.The shorter catheter is by design for our 0.56in variant of the product.Personnel failing to follow line clearance protocols serves as the most likely origin for this non-conformance.H3 other text : see h.10.
 
Event Description
It has been reported that one bd intima-ii¿ closed iv catheter system has been found containing mixed product during use.The following has been provided by the initial reporter: it was found extravasation, catheter was shorter than usual, and felt dull.Google translation: after the puncture ended the afternoon of the stay, an external seepage occurred, and after the nurse pulled out the needle, checked the length of the catheter and found that the catheter was shorter than usual.Other nurses also reacted to this batch of retention needles obviously feel the strong feeling of the back-retracting needle core, not good to fight, affecting the success rate of puncture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD.
9 rui pu road export zone b
suzhou
MDR Report Key8837388
MDR Text Key152531619
Report Number3006948883-2019-00602
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 08/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/12/2021
Device Catalogue Number383083
Device Lot Number8262052
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/03/2019
Initial Date Manufacturer Received 05/16/2019
Initial Date FDA Received07/29/2019
Supplement Dates Manufacturer Received05/16/2019
Supplement Dates FDA Received08/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-